Influence of Pharmaceutical Lobbies on Price Regulation in France and Germany: A Comparative Analysis
Download
Read an extract
Themes
Pharmaceutical lobbying, interest groups, France, Germany, healthcare policies, price regulation, European Union, National Assembly, pharmaceutical industry, Medicines shortages
Reader
Abstract
Extract
of 3
Abstract
Discover how pharmaceutical interest groups influence institutions in France and Germany, shaping the future of healthcare. This insightful analysis by Zeliha Chaffin, a scientific journalist at Le Monde, explores the complex relationships between pharmaceutical lobbies, governments, and regulatory bodies. Learn about the economic weight of pharmaceutical interest groups, their lobbying strategies, and the impact on price regulation. Understand the differences between France's statist approach and Germany's pluralist model, and how these approaches affect the accessibility of medicines. Dive into the details of the National Assembly's unanimous decision to establish a floor stock obligation to combat essential medicines shortages. Uncover the intricate dynamics between interest groups, governments, and the pharmaceutical industry, and gain valuable insights into the future of healthcare policy.
Extract
[...] II- French and German interest groups in the influence of political decision-making between a statist approach and a pluralist approach Their influences are mainly made economically as we have seen in the first part. The expenses are diverse; public communication campaigns, surveys and polls, expert conferences . But also exhibitions within parliaments and/or detailed reports for elected officials. The pressure groups try to push the government towards an increase in prices, but so that medicines remain accessible, the French government establishes a ceiling (in the article it is 4 months). The article highlights the strong pressures exercised by interest groups on the government. [...]
[...] The latter legislate so that medicines do not jeopardize Social Security by being too expensive. Interest groups play a role in contemporary political systems, the objective being the interpretation of the various relationships between them and the State from one country to another. The main mode of action, even if it is not the only one, is an attempt at governance, particularly with the State. Interest groups therefore act according to the political and institutional context. Pharmaceutical lobbies, by adapting to the context, contribute to shaping or evolving the situation. [...]
[...] The approach of interest groups of interest is then pluralistic, as they are present within the Bundestag and strongly influence decisions through 'soft pressures'. (According to La politique du médicament en Allemagne, Valérie Paris in Revue française des affaires sociales, 2007). In France, the proposed law highlights the statist approach, In the end, the exception of the French model or the government legislates tends to extend to Germany, which has introduced several reforms (2004, 2007) even if the latter have not been successful. [...]
[...] Conversely, the institutional and political context does not give rise to a single type of organization or strategy either. Organizations and their relations with political authorities are in permanent interaction.' Thus, the role of lobbies in France as in Germany is to defend their interests, by engaging directly with the political decision-maker, demonstrating the internal character of their lobbying. In Germany, the presence of interest groups in the Bundestag sufficiently demonstrates internal lobbying. All these changes in regulations affecting the price are the main issue of the lobbying of pharmaceutical companies. [...]
[...] According to the definition, interest groups are collective organizations defending groups or principles by intervening with political institutions, either directly or indirectly. They can be divided into lobbies such as that of pharmaceutical products, particularly by participating in the fixing and regulation of prices. How do pharmaceutical interest groups influence institutions in France and Germany: towards a convergence of state approaches? The action of interest groups in the search for the fixing of prices of pharmaceutical products In France as in Germany, pharmaceutical lobbies represent a significant economic weight. [...]
